Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Koeberle D, Tschanz B, Rauch D, Peck-Radosavljevic M, Veilchenfeldt J, Lakatos G, Montemurro M, Wagner A, Buehlmann M, Horber D, Roth A, Saletti P, Samaras P, Ribi K, Li Q, Demeter G, Dufour J, Bodocky G. Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Ann Oncol 2016; 27:856-861.